HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $276 | +6.2% | 7,234 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $260 | -16.1% | 7,218 | -11.1% | 0.00% | -50.0% |
Q1 2023 | $310 | -35.7% | 8,119 | -4.2% | 0.00% | -33.3% |
Q4 2022 | $482 | -99.9% | 8,475 | -5.6% | 0.00% | +50.0% |
Q3 2022 | $355,000 | +3.8% | 8,980 | +15.7% | 0.00% | 0.0% |
Q2 2022 | $342,000 | +13.2% | 7,762 | +2.6% | 0.00% | +100.0% |
Q1 2022 | $302,000 | -5.3% | 7,562 | -4.7% | 0.00% | 0.0% |
Q4 2021 | $319,000 | +15.2% | 7,934 | +16.6% | 0.00% | 0.0% |
Q3 2021 | $277,000 | +16.9% | 6,806 | +30.4% | 0.00% | 0.0% |
Q2 2021 | $237,000 | -7.8% | 5,218 | -15.3% | 0.00% | 0.0% |
Q1 2021 | $257,000 | -1.9% | 6,157 | +0.4% | 0.00% | -50.0% |
Q4 2020 | $262,000 | +3.6% | 6,134 | -35.0% | 0.00% | 0.0% |
Q2 2020 | $253,000 | +36.0% | 9,435 | -10.0% | 0.00% | +100.0% |
Q4 2019 | $186,000 | +13.4% | 10,483 | -0.9% | 0.00% | 0.0% |
Q3 2019 | $164,000 | -14.6% | 10,582 | -5.4% | 0.00% | -50.0% |
Q2 2019 | $192,000 | +2.1% | 11,182 | -4.3% | 0.00% | 0.0% |
Q1 2019 | $188,000 | +13.9% | 11,682 | +3.4% | 0.00% | 0.0% |
Q4 2018 | $165,000 | -19.5% | 11,300 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $205,000 | – | 11,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |